GTC Biotherapeutics (fka GTCB)

[MTB]

After the windfall of SIRT yesterday, I too added a few thousand more at .60 this afternoon.

GTCB is far and away my largest biotech speculative holding (at this point, my only:), and my expectations for its future potential gains certainly dwarf those of the recent much appreciated 80% gains on SIRT.

While I'm typically a buy and hold investor, I came pretty close to selling my 'nonperforming' SIRT holding late last week if only because it had been sitting 'too low for too long' . . .

I will be surprised if continued confidence in GTCB's HUGELY undervalued potential will not be even more handsomely rewarded -- it is just a question of when.

Cheers,
MTB